BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20237670)

  • 21. Enzymatic synthesis of UDP-galactofuranose and an assay for UDP-galactopyranose mutase based on high-performance liquid chromatography.
    Lee R; Monsey D; Weston A; Duncan K; Rithner C; McNeil M
    Anal Biochem; 1996 Nov; 242(1):1-7. PubMed ID: 8923956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymatic synthesis of UDP-(3-deoxy-3-fluoro)-D-galactose and UDP-(2-deoxy-2-fluoro)-D-galactose and substrate activity with UDP-galactopyranose mutase.
    Barlow JN; Blanchard JS
    Carbohydr Res; 2000 Oct; 328(4):473-80. PubMed ID: 11093703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Convergent and stereoselective synthesis of iminosugar-containing Galf and UDP-Galf mimicks: evaluation as inhibitors of UDP-Gal mutase.
    Liautard V; Desvergnes V; Itoh K; Liu HW; Martin OR
    J Org Chem; 2008 Apr; 73(8):3103-15. PubMed ID: 18358048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of Mycobacteria tuberculosis and Klebsiella pneumoniae UDP-galactopyranose mutase in the oxidised state and Klebsiella pneumoniae UDP-galactopyranose mutase in the (active) reduced state.
    Beis K; Srikannathasan V; Liu H; Fullerton SW; Bamford VA; Sanders DA; Whitfield C; McNeil MR; Naismith JH
    J Mol Biol; 2005 May; 348(4):971-82. PubMed ID: 15843027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sugar nucleotide recognition by Klebsiella pneumoniae UDP-D-galactopyranose mutase: fluorinated substrates, kinetics and equilibria.
    Errey JC; Mann MC; Fairhurst SA; Hill L; McNeil MR; Naismith JH; Percy JM; Whitfield C; Field RA
    Org Biomol Chem; 2009 Mar; 7(5):1009-16. PubMed ID: 19225684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steric Control of the Rate-Limiting Step of UDP-Galactopyranose Mutase.
    Pierdominici-Sottile G; Cossio-Pérez R; Da Fonseca I; Kizjakina K; Tanner JJ; Sobrado P
    Biochemistry; 2018 Jul; 57(26):3713-3721. PubMed ID: 29757624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent ligands for prokaryotic UDP-galactopyranose mutase that exploit an enzyme subsite.
    Dykhuizen EC; Kiessling LL
    Org Lett; 2009 Jan; 11(1):193-6. PubMed ID: 19067595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic investigation of UDP-galactopyranose mutase from Escherichia coli using 2- and 3-fluorinated UDP-galactofuranose as probes.
    Zhang Q; Liu H
    J Am Chem Soc; 2001 Jul; 123(28):6756-66. PubMed ID: 11448178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of a novel UDP-carbasugar as UDP-galactopyranose mutase inhibitor.
    El Bkassiny S; N'Go I; Sevrain CM; Tikad A; Vincent SP
    Org Lett; 2014 May; 16(9):2462-5. PubMed ID: 24746099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemistry and biology of galactofuranose-containing polysaccharides.
    Richards MR; Lowary TL
    Chembiochem; 2009 Aug; 10(12):1920-38. PubMed ID: 19591187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand binding and substrate discrimination by UDP-galactopyranose mutase.
    Gruber TD; Borrok MJ; Westler WM; Forest KT; Kiessling LL
    J Mol Biol; 2009 Aug; 391(2):327-40. PubMed ID: 19500588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. X-ray crystallography reveals a reduced substrate complex of UDP-galactopyranose mutase poised for covalent catalysis by flavin.
    Gruber TD; Westler WM; Kiessling LL; Forest KT
    Biochemistry; 2009 Oct; 48(39):9171-3. PubMed ID: 19719175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstitution of UDP-galactopyranose mutase with 1-deaza-FAD and 5-deaza-FAD: analysis and mechanistic implications.
    Huang Z; Zhang Q; Liu HW
    Bioorg Chem; 2003 Dec; 31(6):494-502. PubMed ID: 14613770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tetrafluorination of sugars as strategy for enhancing protein-carbohydrate affinity: application to UDP-Galp mutase inhibition.
    N'Go I; Golten S; Ardá A; Cañada J; Jiménez-Barbero J; Linclau B; Vincent SP
    Chemistry; 2014 Jan; 20(1):106-12. PubMed ID: 24311368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Crystallo Capture of a Covalent Intermediate in the UDP-Galactopyranose Mutase Reaction.
    Mehra-Chaudhary R; Dai Y; Sobrado P; Tanner JJ
    Biochemistry; 2016 Feb; 55(6):833-6. PubMed ID: 26836146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of binding of UDP-Galf and UDP-[3-F]Galf to UDP-galactopyranose mutase by STD-NMR spectroscopy, molecular dynamics, and CORCEMA-ST calculations.
    Yuan Y; Bleile DW; Wen X; Sanders DA; Itoh K; Liu HW; Pinto BM
    J Am Chem Soc; 2008 Mar; 130(10):3157-68. PubMed ID: 18278916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QM/MM molecular dynamics study of the galactopyranose → galactofuranose reaction catalysed by Trypanosoma cruzi UDP-galactopyranose mutase.
    Pierdominici-Sottile G; Cossio Pérez R; Galindo JF; Palma J
    PLoS One; 2014; 9(10):e109559. PubMed ID: 25299056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new methodology for the synthesis of fluorinated exo-glycals and their time-dependent inhibition of UDP-galactopyranose mutase.
    Caravano A; Dohi H; Sinaÿ P; Vincent SP
    Chemistry; 2006 Apr; 12(11):3114-23. PubMed ID: 16429471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis of ligand binding to UDP-galactopyranose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogues.
    van Straaten KE; Kuttiyatveetil JR; Sevrain CM; Villaume SA; Jiménez-Barbero J; Linclau B; Vincent SP; Sanders DA
    J Am Chem Soc; 2015 Jan; 137(3):1230-44. PubMed ID: 25562380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational Control of UDP-Galactopyranose Mutase Inhibition.
    Wangkanont K; Winton VJ; Forest KT; Kiessling LL
    Biochemistry; 2017 Aug; 56(30):3983-3992. PubMed ID: 28608671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.